We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

First Off-the-Shelf Immunotherapy Clinical Trial Launched

News   Apr 11, 2019 | Original story by Yadira Galindo, UC San Diego Health

 
First Off-the-Shelf Immunotherapy Clinical Trial Launched

Sandip Patel, MD, and Dan Kaufman, MD, PhD, of UC San Diego School of Medicine enjoy a light-hearted moment before Derek Ruff receives the first treatment for cancer of a human-induced pluripotent stem cell (iPSC)-derived cell therapy called FT500. Image credit: UC San Diego Health

 
 
 

RELATED ARTICLES

Hole-forming Protein May Suppress Tumor Growth

News

Jefferson researchers show a gene called gasdermin E, which is downregulated in many cancers, aids cells in dying in an unexpected way, and may also suppress tumor growth.

READ MORE

Biologists Design Molecules That “Starve” Lung Cancer Cells

News

University of Texas at Dallas scientists have demonstrated that the growth rate of the majority of lung cancer cells relates directly to the availability of a crucial oxygen-metabolizing molecule. Researchers have engineered and extensively characterized new molecules aimed at starving the cancer cells of the molecule that allows them to proliferate so quickly.

READ MORE

Insights on Marijuana and Opioid Use in People With Cancer

News

A new study reveals that many people with cancer use marijuana, and rates of use in the U.S. have increased over time.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE